These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33838296)

  • 1. Impact of the immunotherapy induction on allograft outcome and survival in kidney transplant patients with donor-specific antibodies to HLA-DQB1.
    Dutra RS; Fabreti-Oliveira RA; Lasmar MF; Araujo SA; Nascimento E
    Transpl Immunol; 2021 Jun; 66():101390. PubMed ID: 33838296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcome of Kidney Transplant Patients on the Allograft Function, Loss, Effects of HLA-DQB1-DSA
    Cunha APL; Fabreti-Oliveira RA; Lasmar MF; Garcia JC; Vilela TP; Nascimento E
    Transplant Proc; 2021 Sep; 53(7):2188-2196. PubMed ID: 34420780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.
    Thammanichanond D; Tammakorn C; Worawichawong S; Kantachuvesiri S
    Transplant Proc; 2020; 52(6):1931-1936. PubMed ID: 32444122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
    Wehmeier C; Hönger G; Cun H; Amico P; Hirt-Minkowski P; Georgalis A; Hopfer H; Dickenmann M; Steiger J; Schaub S
    Am J Transplant; 2017 Aug; 17(8):2092-2102. PubMed ID: 28245084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant.
    Kitpermkiat R; Kantachuvesiri S; Thotsiri S; Thammanichanond D; Rostaing L; Wiwattanathum P
    Transpl Immunol; 2024 Jun; 84():102054. PubMed ID: 38750972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection.
    Lasmar MF; Dutra RS; Nogueira-Machado JA; Fabreti-Oliveira RA; Siqueira RG; Nascimento E
    BMC Nephrol; 2019 Aug; 20(1):314. PubMed ID: 31409321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-transplant crossmatch-negative donor-specific anti-HLA antibody predicts acute antibody-mediated rejection but not long-term outcomes in kidney transplantation: an analysis of the Korean Organ Transplantation Registry.
    Lee H; Lee H; Sun IO; Park JH; Park JW; Ban TH; Yang J; Kim MS; Yang CW; Chung BH;
    Front Immunol; 2024; 15():1420351. PubMed ID: 39055708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Antibodies against Angiotensin II Type-1 Receptor on the Outcome of Kidney Transplantation: A Single-Center Retrospective Study.
    Filiopoulos V; Vittoraki A; Vallianou K; Bellos I; Markaki P; Liapis G; Marinaki S; Iniotaki A; Boletis IN
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Mediated Rejection Due to Preexisting versus
    Aubert O; Loupy A; Hidalgo L; Duong van Huyen JP; Higgins S; Viglietti D; Jouven X; Glotz D; Legendre C; Lefaucheur C; Halloran PF
    J Am Soc Nephrol; 2017 Jun; 28(6):1912-1923. PubMed ID: 28255002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.
    Callemeyn J; Lerut E; de Loor H; Arijs I; Thaunat O; Koenig A; Meas-Yedid V; Olivo-Marin JC; Halloran P; Chang J; Thorrez L; Kuypers D; Sprangers B; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2168-2183. PubMed ID: 32641395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific antibody to trans-encoded donor HLA-DQ heterodimer.
    Habig DF; Gaspari JL; Lokhandwala PM; Domen RE; Abendroth CS; Kadry Z; Ghahramani N; Shah RA; Jain A; Shike H
    Hum Immunol; 2015 Aug; 76(8):587-90. PubMed ID: 26382246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
    Kwon H; Kim YH; Choi JY; Shin S; Jung JH; Park SK; Han DJ
    Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of HLA-DQ Matching on Allograft Outcomes in Deceased Donor Kidney Transplantation.
    Khongjaroensakun N; Kitpoka P; Wiwattanathum P; Sakulchairungrueng B; Thammanichanond D
    Transplant Proc; 2018 Oct; 50(8):2371-2376. PubMed ID: 30316360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific anti-HLA antibodies in pediatric renal transplant recipients with creeping creatinine: Prevalence, histological correlations, and impact on patient and graft survival.
    Monteverde ML; Chaparro A; Goldberg J; Marcos CY; Padros K; Balbarrey Z; Briones L; Rush D
    Pediatr Transplant; 2015 Nov; 19(7):684-90. PubMed ID: 26212912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies.
    Halloran PF; Famulski KS; Chang J
    Am J Transplant; 2017 Jan; 17(1):129-139. PubMed ID: 27340822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.
    Bailly E; Anglicheau D; Blancho G; Gatault P; Vuiblet V; Chatelet V; Morelon E; Malvezzi P; Parissiadis A; Tourret J; Guidicelli G; Sayegh J; Mousson C; Grimbert P; Top I; Le Quintrec M; Purgus R; Westeel PF; Proust B; Chabot V; Lebranchu Y; Dehaut F; Büchler M
    Transplantation; 2018 Apr; 102(4):688-698. PubMed ID: 29135832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.